Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_assertion type Assertion NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_head.
- NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_assertion wasGeneratedBy ECO_0000203 NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_provenance.
- NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_assertion wasDerivedFrom befree-20150227 NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_provenance.
- NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_assertion SIO_000772 9041943 NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_provenance.
- NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_assertion evidence source_evidence_literature NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_provenance.
- NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_assertion description "[Based on these data, we conclude that accelerated in vitro apoptosis and increased Fas/ APO-1 and bcl-2 protein expression in SLE are nonspecific for the disease, and might be explained at least in part by the increased in vivo activation levels of PBMC from patients with SLE, MCTD, or autoimmune vasculitides combined with in vitro incubation under 'noninflammatory' conditions and growth factor withdrawal.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262769.RAB49yDYAVaMNH4nmiQNK1BijzY0b87xzBZCGOM5lEVEk130_provenance.